27 Jan 2020 - 28 Jan 2020 | Graz, Austria


27 Jan 2020
09:00 – 10:00
10:00 – 10:30
Opening session

Sandra Holasek, member of the Styrian parliament

Wolfgang Pribyl, JOANNEUM RESEARCH Forschungsgesellschaft mbH
Christoph Ludwig, SFG
Andrea Keimel, City of Graz

10:30 – 11:15

Johanna Pirker, Graz University of Technology: "It's not just a game. It's a game changer - games, gamification and virtual reality experiences for medical applications."

Johannes Khinast, CEO & Scientific Director of RCPE: "Personalized Medicine - Chances and Challenges of a Paradigm Shift": Personalized medicine does not follow a "one-size-fits-all" treatment approach but emphasizes "tailor-made" delivery, meaning it addresses the patient’s individual situation and most notably his or her genetic markers. For patients, this increases the chances of treatment success and translates into fewer side effects. In particular, malignant tumors with a large variety of genes involved can be treated more effectively. However, currently only a small part of biomolecular targets can be “drugged”, which offers a tremendous potential for future breakthroughs in the pharmaceutical industry. Another main challenge is the formulation, manufacturing and delivery of individualized drugs. Here completely new routes have to be explored and a paradigm shift how we make such drugs is in the horizon. Again, this offers major opportunities for innovative companies and novel products.

11:15 – 11:45
11:45 – 13:30
Investor Pitching

In order to secure dynamic growth of start-ups and scale-ups, entrepreneurs get the unique chance to pitch to renowned international investors who are willing to drive entrepreneurial success to the next level through potential investments, expertise, network, advice and mentoring.

Take a look at the participating investors!

13:30 – 14:30
14:00 – 15:00
B2B meetings
1:1 Meetings
15:00 – 15:15
15:15 – 17:00
Research Project Pitching

This session offers researchers the possibility to present their latest research findings to an audience of investors, industry partners and fellow researchers. It is a unique opportunity to identify new collaboration or investment partners and receive input on how to translate your research results into applicable products in a relevant market.

Take a look at the pitching researchers!

17:00 – 17:30
B2B meetings
1:1 Meetings
18:30 – 21:00
Social event in the Town Hall of Graz-FULLY BOOKED!

The Mayor of Graz Mr. Siegfried Nagl extends a warm welcome to HTH 2020 guests and is delighted to welcome them to conclude the first evening of this Pitch & Partner event with dinner and a get together in the town hall of Graz.

Location: Town Hall, Hauptplatz 1, 8010 Graz, 2nd floor, hall of the local council

Tram line nr. 7, get off at Hauptplatz (Main Square, Congress Center)

Registration is required and compulsary! 

We are fully booked and cannot accomodate any further registrations!

28 Jan 2020
08:30 – 09:00
09:00 – 10:30

Yupar Myint, Head of Entrepreneurship at Maxwell Centre, University of Cambridge: „The role of serial entrepreneurs in the incubation of new ventures: Cambridge Experience”

Klara Brandstätter, Project Lead, I.E.C.T. Hermann Hauser: "Science-Based Entrepreneurship: A Scale-Up Journey"

10:30 – 11:00
11:00 – 12:45
Corporate Challenge

Corporates and start-ups present the best solutions to the following topics

Reha-Patient Relationship Management 
moderated by Sanlas Holding

Diagnostics, prevention & management of patients with dementia and enhanced workflows in nursing homes
moderated by Geriatric Health Centres of the City of Graz

Business models for AAL solutions in the B2B and B2C sector
moderated by E-Steiermark

Next generation medical sensing
moderated by ams AG

12:45 – 13:45
13:15 – 14:15
B2B meetings
1:1 Meetings
14:15 – 14:30
14:30 – 16:15
International Collaborative Project Presentation

In this session, consortia of large projects have the opportunity to present themselves and to gather recommendations for existing problems from a panel of experts representing different areas. A common challenge for such consortia is the “next step” as in the potential commercialisation and marketing of the research results or the developed product. This session will therefore be designed in order to address these problems with a view to facilitating the next steps. The panel comprises:

Klara Brandstätter, I.E.C.T.
Alexander Fein, Peak Pride
Michael Kerschbaumer, SFG
Georg Kraft-Kinz, KraftKinzKraft
Martin Mössler, Science Park Graz
Thomas Riener, AMS AG
Caroline Schober-Trummler, Med Uni Graz
Jürgen Zinka, Consiga & Partner

16:15 – 16:45
B2B meetings
1:1 Meetings
The event agenda's time zone is CEST.